BM&FBOVESPA S.A. (ticker: BVMF3) today reported its third-quarter earnings for the period ending on September 30, 2015. In this quarter, earnings were impacted by two non-recurring events related to the CME Group: the results from the partial divestment (1% of the total CME Group Shares) and the discontinuity of the equity method of accounting for the remaining investment (4% of the total CME Group Shares).
BM&FBOVESPA reaffirms its previously announced budget ranges: (i) adjusted expenses2 (OPEX) of R$590 million to R$615 million for 2015; and (ii) capital expenditures (CAPEX) of R$200 million to R$2302015 and of R$165 million to R$195 million for 2016.
Click here for full details.
